Linklaters acted for OmnigenicsAI Corp (Bioceres Group Plc), Greenberg Traurig advised APx Acquisition Corp. I. APx Acquisition Corp. I (NASDAQ: APXI), a publicly traded special purpose...
Linklaters acted for OmnigenicsAI Corp (Bioceres Group Plc), Greenberg Traurig advised APx Acquisition Corp. I. APx Acquisition Corp. I (NASDAQ: APXI), a publicly traded special purpose...
You must be a Standard 1 Year member to access this content.